SIMAGO
Acquired by
ARDIAN
SIMAGO acquired by ARDIAN
Target
SIMAGO
Acquirer
ARDIAN
Context
Ardian acquired a significant minority stake in Simago. The investment was designed to support the group's rapid "buy-and-build" strategy in a highly fragmented French market. Unlike traditional LBOs, the deal was structured to preserve the medical independence of the associate radiologists, who continue to hold the majority of the capital and voting rights alongside the founding management team.
SIMAGO, which reported an EBITDA margin of LOGIN in 2021, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN premium to the 12.8x average currently observed in the Healthcare & Pharma sector.
Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.
-> Deep-dive in Healthcare & Pharma market trends
Target
Founded in 2019, Simago is a leading French medical imaging network. It operates as a "third way" consolidation platform, partnering with independent radiologists while allowing them to remain active associates in their clinics. At the time of the deal, the group managed a network of 28 centers across France, operating 16 MRI scanners and 15 CT scanners, with a medical team of 78 radiologists. Simago specializes in the full spectrum of diagnostic services, including MRI, CT, ultrasound, and mammography.
Ent. Value
LOGIN
Equity Value
LOGIN
Multiples Analysis
EV / Revenue
LOGIN
EV / EBITDA
LOGIN
EV / EBIT
LOGIN
Historical Financials (EUR)
Other operations with SIMAGO
mynth data is contributed by M&A / PE professionals and systematically cross-verified against private deal documents and official releases. All source materials are destroyed post-validation to guarantee data anonymity and compliance.